Germany Ophthalmic Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Germany Ophthalmic Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Germany Ophthalmic Devices market is expected to register a CAGR of 6.1% over the forecast period.

The COVID-19 pandemic had interrupted the healthcare services provided all over the nation. Most of the general medical services that were not urgent were postponed to prevent the further spread of the pandemic. Several ophthalmologic surgeries, which were deemed not urgent, were also postponed. The ophthalmic devices market in Germany faced several restrictions during the COVID-19 pandemic. An article titled "Impact of the SARS-CoV-2 pandemic on ophthalmic care in Germany" published in the journal of Ophthalmologe in July 2021 indicated that during the pandemic period, with the exception of endophthalmitis, almost all ophthalmic procedures, including retinal detachment, perforating eyeball injuries, acute glaucoma, central retinal artery occlusion, anterior ischemic optic neuropathy, penetrating keratoplasty, and amniotic membrane transplantation, among others, were declined. The decrease in ophthalmic patient care in the nation during the COVID-19 pandemic significantly affected the growth of the ophthalmic devices market.

Ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. These devices have gained increasing importance and adoption due to the high prevalence of various ophthalmic diseases such as glaucoma, cataract, retinal detachment, and other vision-related issues across the country. An article titled "Incidence of Retinal Detachment in Germany: Results from the Gutenberg Health Study" published in the journal of Ophthalmologica in May 2021 indicated that in Germany, retinal detachment disease had an incidence rate of 42 per 100,000 people per year for the age group of 35-74 years. The study estimated that the incidence of retinal detachment in Germany at the age of 35–74 years is high in comparison to estimates from neighboring European countries. Such a high prevalence of ophthalmic disorders is expected to boost the market's growth over the forecast period.

Moreover, technological advancements and product approvals in the field have boosted the adoption rate of devices in the nation. In June 2021, Implandata Ophthalmic Products, a digital health company, obtained a CE mark for its EYEMATE-SC biosensor. The device will be used in conjunction with the pioneering EYEMATE system for digitally enabled remote glaucoma monitoring and management. EYEMATE-SC is an improved version of its predecessor.

Thus, due to the aforementioned factors, the market for ophthalmic devices in Germany is anticipated to grow. However, although there have been advancements, the devices are still deemed unsafe and can cause damage if not handled professionally. Hence, such factors may restrain the market's growth over the coming years.

Key Market TrendsLasers are Expected to Register a High CAGR over the Forecast Period.

Ophthalmic lasers are used to aid and improve vision for those with common refractive errors like myopia, hypermetropia, astigmatism, and presbyopia. These visual impairments result in low vision. Moreover, the rise in these conditions is expected to boost the growth of the market segment.

As per the January 2022 estimates by the Federal Statistical Office (Destatis), 16.2 million people over the age of 67 years old lived in Germany at the end of the year 2021. The same source projected that the number would rise to 21.6 by the year 2060. The rising geriatric population is likely to propel the segment's growth in the nation over the forecast period as this population is more vulnerable to eye-related disorders. Furthermore, the elderly population is more prone to illness and poor vision. In addition, as this population grows, the demand for vision correction surgeries is likely to increase, in turn boosting the demand for laser devices.

Strategic initiatives by key players are also expected to contribute to the segment's growth. For instance, in July 2022, MaxiVision Eye Hospital introduced Technolas Teneo 317 Model 2 (Teneo M2). The Teneo M2 is an advanced, high-performance excimer laser, designed with expert German engineering design. The device provides customized treatments for a wide range of patients, correcting presbyopia, myopia, hyperopia, and astigmatism. TENEO M2's unique SUPRACOR treatment is a true progressive LASIK for presbyopic patients for improved vision without glasses for most daily activities. Such product launches by German ophthalmic device manufacturers are expected to boost the growth of the segment over the forecast period.

Thus, due to the above-mentioned factors, the laser segment is expected to grow significantly during the forecast period.

Competitive Landscape

Germany has a well-structured and developed healthcare system. Germany also promotes research and development for pharmaceutical devices and hence records very high expenditure on healthcare. As a result of these policies, many companies globally are encouraged to operate in the region, which makes the market competitive. Some of the major key players in the region include Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, EssilorLuxottica SA, HAAG-Streit Group, Hoya Corporation, Johnson & Johnson, Nidek Co. Ltd., Topcon Corporation, and Ziemer Ophthalmic Systems AG, among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.